|
- EOHILIA™ (budesonide oral suspension) Website for U. S. Residents
EOHILIA (budesonide oral suspension) is a prescription oral corticosteroid medicine used for 12 weeks of treatment of Eosinophilic Esophagitis (EoE), in people 11 years and older EOHILIA has not been shown to be safe and effective for the treatment of EoE for longer than 12 weeks
- What to expect while taking EOHILIA
EOHILIA (budesonide oral suspension) is a prescription oral corticosteroid medicine used for 12 weeks of treatment of Eosinophilic Esophagitis (EoE), in people 11 years and older EOHILIA has not been shown to be safe and effective for the treatment of EoE for longer than 12 weeks
- What is EoE? - EOHILIA™
EOHILIA (budesonide oral suspension) is a prescription oral corticosteroid medicine used for 12 weeks of treatment of Eosinophilic Esophagitis (EoE), in people 11 years and older EOHILIA has not been shown to be safe and effective for the treatment of EoE for longer than 12 weeks
- About EOHILIA™ (budesonide oral suspension) - How it Works How to Take It
EOHILIA (budesonide oral suspension) is a prescription oral corticosteroid medicine used for 12 weeks of treatment of Eosinophilic Esophagitis (EoE), in people 11 years and older EOHILIA has not been shown to be safe and effective for the treatment of EoE for longer than 12 weeks
- Getting Started | EOHILIA™ (budesonide oral suspension)
Learn how to get started with EOHILIA™ (budesonide oral suspension) treatment for EoE including talking to your doctor and managing costs See Important Safety Information and Prescribing Information
- Why EOHILIA™ (budesonide oral suspension)? Clinical Results Safety . . .
EOHILIA (budesonide oral suspension) is a prescription oral corticosteroid medicine used for 12 weeks of treatment of Eosinophilic Esophagitis (EoE), in people 11 years and older EOHILIA has not been shown to be safe and effective for the treatment of EoE for longer than 12 weeks
- Resources | EOHILIA™ (budesonide oral suspension)
EOHILIA (budesonide oral suspension) is a prescription oral corticosteroid medicine used for 12 weeks of treatment of Eosinophilic Esophagitis (EoE), in people 11 years and older EOHILIA has not been shown to be safe and effective for the treatment of EoE for longer than 12 weeks
- The EOHILIA Patient Support and Copay Program
EOHILIA (budesonide oral suspension) is a prescription oral corticosteroid medicine used for 12 weeks of treatment of Eosinophilic Esophagitis (EoE), in people 11 years and older EOHILIA has not been shown to be safe and effective for the treatment of EoE for longer than 12 weeks
|
|
|